COVID-19 Treatment
Pneumagen Ltd Announces Positive Anti-Viral Activity for Novel Glycan Approach in Preventing Coronavirus Infections
Pneumagen
PR-M04-20-NI-038Apr 28, 2020
Coronavirus
Pneumagen Ltd Leverages its Novel Glycan Approach to Target Coronavirus (COVID-19) Infections
Pneumagen
PR-M03-20-NI-024Mar 17, 2020